Relapsed Adult AML Clinical Trials in Lille
2 recruitingLille, France
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19
Relapsed Adult AML
University Hospital, Lille5 enrolled1 locationNCT06649227
Recruiting
Phase 2
Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
AML, AdultRefractory AMLRelapsed Adult AML+2 more
French Innovative Leukemia Organisation33 enrolled20 locationsNCT06022003